Basic info
Industry
biotechnology research
Sectors
Pharmaceutical
Biotechnology
Genetic Respiratory Disease
RNA Therapies
Biopharma
Non-Viral Lipid Nanoparticles
Cystic Fibrosis
Genetic Medicines
Genetics
Primary Ciliary Dyskinesia
Date founded
2015
Funding rounds raised
Total raised
$210M
from 21 investors over 21 rounds
R
ReCode Therapeutics raised $50M on September 19, 2023
Investors: Sanofi Ventures, OrbiMed Advisors, Solasta Ventures, Vida Ventures, LLC, Leaps by Bayer, Osage University Partners (OUP) and MPM Capital
R
ReCode Therapeutics raised $120M on June 29, 2022
Investors: Sanofi Ventures and Leaps by Bayer
R
ReCode Therapeutics raised $210M on October 21, 2021
Investors: Sanofi Ventures, NS Investment, -, OrbiMed Advisors, Vida Ventures, LLC, Tekla Capital Management, Osage University Partners (OUP) and MPM Capital
R
ReCode Therapeutics raised $80M on March 26, 2020
Investors: OrbiMed Advisors, Osage University Partners (OUP), Vida Ventures, LLC and MPM Capital